Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (29 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 31 Jan 2024 – 20 Aug 2026, limited by DSP Multicap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | DSP Multicap Fund | Nifty 500 |
|---|---|---|
| 31 Jan 2024 | ₹100.00 | ₹100.00 |
| 18 Apr 2024 | ₹102.28 | ₹102.64 |
| 04 Jul 2024 | ₹121.01 | ₹115.72 |
| 20 Sep 2024 | ₹128.54 | ₹122.18 |
| 07 Dec 2024 | ₹125.33 | ₹117.73 |
| 22 Feb 2025 | ₹107.44 | ₹104.49 |
| 11 May 2025 | ₹111.38 | ₹109.46 |
| 28 Jul 2025 | ₹123.22 | ₹115.38 |
| 13 Oct 2025 | ₹124.52 | ₹117.64 |
| 30 Dec 2025 | ₹123.10 | ₹119.53 |
| 18 Mar 2026 | ₹104.53 | ₹110.68 |
| 03 Jun 2026 | ₹110.76 | ₹113.38 |
| 20 Aug 2026 | ₹118.83 | ₹118.74 |
| Metric | DSP · Direct · IDCW NAV ₹11.91 Very High risk ★★☆☆☆ 1Y | Category median Multi Cap Fund · 29 funds |
|---|---|---|
| -5.00% | +6.55% | |
| — | +13.71% | |
| — | +12.07% | |
| — | +9.16% | |
| +7.00% | +14.55% | |
| +1.77% | — | |
| — | +17.33% | |
| — | +14.39% | |
| — | +9.74% | |
| Risk | ||
| 15.87% | 15.40% | |
| -0.72 | 0.41 | |
| -0.93 | 0.54 | |
| -24.94% | -21.00% | |
| Nifty 500 | — | |
| +0.37% | +1.30% | |
| 1.06 | 1.03 | |
| 99.3% | 104.7% | |
| 98.9% | 99.6% | |
| 0.70% | 0.93% | |
| ₹2,765Cr | ₹4,007Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 22% | 53% | |
| Chirag Dagli · 2.6y | — | |
| 31 Jan 2024 | — | |
| 59 | — | |
| 30.5% | — | |
| 10.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.